FI860711A0 - Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. - Google Patents
Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.Info
- Publication number
- FI860711A0 FI860711A0 FI860711A FI860711A FI860711A0 FI 860711 A0 FI860711 A0 FI 860711A0 FI 860711 A FI860711 A FI 860711A FI 860711 A FI860711 A FI 860711A FI 860711 A0 FI860711 A0 FI 860711A0
- Authority
- FI
- Finland
- Prior art keywords
- dessa
- innehaolllande
- dikarboxylsyror
- alfa
- omega
- Prior art date
Links
- 101100148710 Clarkia breweri SAMT gene Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/26—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
- C07C55/28—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/32—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843423166 DE3423166A1 (de) | 1984-06-22 | 1984-06-22 | Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
| PCT/EP1985/000288 WO1986000298A1 (fr) | 1984-06-22 | 1985-06-15 | Acides alpha, omega dicarboxyliques, procede pour leur preparation et medicaments les renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI860711A7 FI860711A7 (fi) | 1986-02-17 |
| FI860711A0 true FI860711A0 (fi) | 1986-02-17 |
Family
ID=6238954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI860711A FI860711A0 (fi) | 1984-06-22 | 1986-02-17 | Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4711896A (enExample) |
| EP (1) | EP0185080B1 (enExample) |
| JP (1) | JPH0780807B2 (enExample) |
| AU (1) | AU4607185A (enExample) |
| CA (1) | CA1262552A (enExample) |
| DD (1) | DD240541A5 (enExample) |
| DE (2) | DE3423166A1 (enExample) |
| DK (1) | DK75986A (enExample) |
| ES (1) | ES8604090A1 (enExample) |
| FI (1) | FI860711A0 (enExample) |
| GR (1) | GR851509B (enExample) |
| HU (1) | HUT38892A (enExample) |
| IL (1) | IL75549A (enExample) |
| NO (1) | NO860661L (enExample) |
| PT (1) | PT80681B (enExample) |
| WO (1) | WO1986000298A1 (enExample) |
| ZA (1) | ZA854684B (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4876279A (en) * | 1986-05-05 | 1989-10-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| IL101708A (en) * | 1992-04-28 | 1996-08-04 | Senyorina Ltd | Anti-fattening drugs comprising amino acid derivatives |
| US5602164A (en) * | 1992-04-28 | 1997-02-11 | Senyorina Ltd. | Anti-obesity drugs |
| TW322493B (enExample) * | 1994-06-27 | 1997-12-11 | Shell Int Research | |
| US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| IL119971A (en) | 1997-01-07 | 2003-02-12 | Yissum Res Dev Co | Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids |
| US20020037876A1 (en) * | 1998-06-25 | 2002-03-28 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| IL121165A0 (en) | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
| US6410802B1 (en) * | 1999-04-01 | 2002-06-25 | Esperion Therapeutics, Inc. | Methods for synthesizing ether compounds and intermediates therefor |
| IL155213A0 (en) | 2000-10-11 | 2003-11-23 | Esperion Therapeutics Inc | Ketone compounds and compositions for cholesterol management and related uses |
| US20040122091A1 (en) * | 2000-10-11 | 2004-06-24 | Esperion Therapeutics, Inc. | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| EP1351916A2 (en) | 2000-10-11 | 2003-10-15 | Esperion Therapeutics Inc. | Ether compounds and compositions for cholesterol management and related uses |
| MXPA03003022A (es) | 2000-10-11 | 2003-07-14 | Esperion Therapeutics Inc | Compuestos de sulfuro y disulfuro y composiciones para el control del colesterol y usos relacionados. |
| BR0114623A (pt) | 2000-10-11 | 2005-12-13 | Esperion Therapeutics Inc | Composto, composição farmacêutica, métodos para tratar ou prevenir uma doença cardiovascular, uma dislipidemia, uma dislipoproteinemia, um distúrbio do metabolismo da glicose, trombótico e associado com o receptor ativado do proliferador de peroxissoma, a doença de alzheimer, a sìndrome x ou sìndrome metabólica, a septicemia, a obesidade, pancreatite, a hipertensão, doença renal, câncer, a inflamação e a impotência, em um paciente e para reduzir o teor de gordura da carne em animal de criação e de colesterol de ovos de aves domésticas |
| US7304093B2 (en) * | 2000-10-11 | 2007-12-04 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
| US20040192771A1 (en) * | 2001-10-11 | 2004-09-30 | Dasseux Jean-Louis Henri | Ether compounds and compositions for cholesterol management and related uses |
| US20050020694A1 (en) * | 2001-10-11 | 2005-01-27 | Dasseux Jean-Louis Henri | Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| US20040204502A1 (en) * | 2001-10-11 | 2004-10-14 | Dasseux Jean-Louis Henri | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| BR0309152A (pt) * | 2002-04-10 | 2007-01-30 | Esperion Therapeutics Inc | composto ou sais, solvatos, hidratos ou pró-drogas deste farmaceuticamente aceitáveis, composição, métodos para tratar ou prevenir uma doença ou condição, uma doença cardiovascular, uma dislipidemia, a hipertensão, o cáncer, a inflamação, e a impotência em um paciente, forma de dosagem unitária, e, método para identificar um composto útil para tratar ou prevenir uma condição em um paciente |
| EP1519751A2 (en) * | 2002-07-03 | 2005-04-06 | Esperion Therapeutics Inc. | Compositions comprising panthetine for the treatment of dyslipidemia |
| US20040048910A1 (en) * | 2002-08-22 | 2004-03-11 | Bove Susan Elizabeth | Method of treating osteoarthritis |
| CA2513660C (en) | 2003-01-23 | 2012-05-08 | Esperion Therapeutics, Inc. | Hydroxyl compounds and compositions for cholesterol management and related uses |
| WO2005002557A1 (en) * | 2003-07-03 | 2005-01-13 | Warner-Lambert Company Llc | Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof |
| ATE428411T1 (de) * | 2003-11-07 | 2009-05-15 | Jj Pharma Inc | Hdl-verstärkende kombinationstherapie-komplexe |
| US20050192347A1 (en) * | 2003-12-23 | 2005-09-01 | Dasseux Jean-Louis H. | Urea and thiourea compounds and compositions for cholesterol management and related uses |
| BR0318685A (pt) | 2003-12-24 | 2006-12-19 | Esperion Therapeutics Inc | compostos de cetona e composições para controle de colesterol e usos relacionados |
| CA2550943A1 (en) * | 2003-12-30 | 2005-07-14 | Syndrome X Ltd. | Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid |
| AU2005255013A1 (en) * | 2004-06-09 | 2005-12-29 | Avanir Pharmaceuticals | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| EP1753733A1 (en) * | 2004-06-09 | 2007-02-21 | Avanir Pharmaceuticals | Small molecules for treatment of hypercholesterolemia and related diseases |
| WO2005123686A1 (en) * | 2004-06-09 | 2005-12-29 | Avanir Pharmaceuticals | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| US7846915B2 (en) * | 2004-10-20 | 2010-12-07 | Resverlogix Corporation | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| WO2007016525A2 (en) * | 2005-07-29 | 2007-02-08 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| EP2118074B1 (en) | 2007-02-01 | 2014-01-22 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| IL181577A0 (en) * | 2007-02-26 | 2007-07-04 | Jacob Bar Tana | Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders |
| EP2431043A1 (en) | 2007-05-23 | 2012-03-21 | Amcol International Corporation | Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption |
| SI2346837T1 (sl) | 2008-06-26 | 2015-05-29 | Resverlogix Corporation | Postopki pripravljanja kinazolinonskih derivatov |
| NZ594332A (en) | 2009-01-08 | 2013-09-27 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular disease |
| CN105859639A (zh) | 2009-03-18 | 2016-08-17 | 雷斯韦洛吉克斯公司 | 新的抗炎剂 |
| CN102458405B (zh) | 2009-04-22 | 2017-06-23 | 雷斯韦洛吉克斯公司 | 新抗炎剂 |
| ES2670576T3 (es) | 2009-09-03 | 2018-05-31 | Pfizer Vaccines Llc | Vacuna de PCSK9 |
| CN103327974A (zh) | 2010-09-20 | 2013-09-25 | 卡留斯治疗公司 | 用于治疗糖尿病和血脂异常的方法和组合物 |
| US20140004142A1 (en) | 2011-03-02 | 2014-01-02 | Pfizer Inc. | Pcsk9 vaccine |
| TR201909777T4 (tr) | 2011-11-01 | 2019-07-22 | Resverlogix Corp | Sübsti̇tüe ki̇nazoli̇nonlara yöneli̇k oral çabuk salimli formülasyonlar |
| WO2013084237A1 (en) | 2011-12-08 | 2013-06-13 | Syndromex Ltd. | Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| CN105073744B (zh) | 2012-12-21 | 2019-11-08 | 齐尼思表观遗传学有限公司 | 作为溴结构域抑制剂的新型杂环化合物 |
| US10279019B2 (en) | 2014-02-11 | 2019-05-07 | Stc.Unm | PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same |
| RU2022102472A (ru) | 2015-03-13 | 2022-03-15 | Эсперион Терапеутикс, Инк. | Фиксированные комбинации и составы, содержащие etc-1002 и эзетимиб, и способы лечения или уменьшения риска развития сердечно-сосудистого заболевания |
| JO3789B1 (ar) | 2015-03-13 | 2021-01-31 | Resverlogix Corp | التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة |
| MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
| CN107118098B (zh) * | 2016-02-25 | 2020-07-14 | 中国科学院上海药物研究所 | 一类脂肪酸类化合物、其制备方法及其用途 |
| US10512624B2 (en) | 2016-11-30 | 2019-12-24 | Syndromex Ltd. | Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1 |
| JP2022537049A (ja) | 2019-06-21 | 2022-08-23 | エスペリオン・セラピューティクス・インコーポレイテッド | ベンペド酸の製造方法及びその組成物 |
| WO2021021563A1 (en) * | 2019-07-26 | 2021-02-04 | Espervita Therapeutics, Inc. | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease |
| MX2023008567A (es) | 2021-01-25 | 2023-08-28 | Espervita Therapeutics Inc | Acidos monocarboxilicos y dicarboxilicos de hidrocarburos de cadena larga funcionalizados y derivados de estos, y su uso para la prevencion o el tratamiento de enfermedades. |
| WO2022159811A1 (en) | 2021-01-25 | 2022-07-28 | Espervita Therapeutics, Inc. | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease |
| CN115894220A (zh) * | 2021-09-23 | 2023-04-04 | 中国科学院上海药物研究所 | 一类作用于acly的长链类化合物、其制备方法及其用途 |
| CN115887435A (zh) * | 2021-09-23 | 2023-04-04 | 博骥源（上海）生物医药有限公司 | 长链类化合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1210786B (de) * | 1962-12-17 | 1966-02-17 | Shell Int Research | Verfahren zur Herstellung von p-Phenylen-bis (3, 3'-isovaleriansaeure) und 3-Phenylisovalerian-saeure |
| GB1556660A (en) * | 1975-10-07 | 1979-11-28 | Akzo Nv | Di-carboxylic acid derivatives |
| IL64542A0 (en) * | 1981-12-15 | 1982-03-31 | Yissum Res Dev Co | Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
-
1984
- 1984-06-22 DE DE19843423166 patent/DE3423166A1/de not_active Withdrawn
-
1985
- 1985-06-15 AU AU46071/85A patent/AU4607185A/en not_active Abandoned
- 1985-06-15 EP EP85903247A patent/EP0185080B1/de not_active Expired
- 1985-06-15 WO PCT/EP1985/000288 patent/WO1986000298A1/de not_active Ceased
- 1985-06-15 US US06/840,563 patent/US4711896A/en not_active Expired - Lifetime
- 1985-06-15 JP JP60503069A patent/JPH0780807B2/ja not_active Expired - Fee Related
- 1985-06-15 HU HU853002A patent/HUT38892A/hu unknown
- 1985-06-15 DE DE8585903247T patent/DE3574130D1/de not_active Expired
- 1985-06-18 IL IL75549A patent/IL75549A/xx not_active IP Right Cessation
- 1985-06-19 DD DD85277529A patent/DD240541A5/de unknown
- 1985-06-20 GR GR851509A patent/GR851509B/el unknown
- 1985-06-21 ES ES544439A patent/ES8604090A1/es not_active Expired
- 1985-06-21 PT PT80681A patent/PT80681B/pt not_active IP Right Cessation
- 1985-06-21 CA CA000484907A patent/CA1262552A/en not_active Expired
- 1985-06-21 ZA ZA854684A patent/ZA854684B/xx unknown
-
1986
- 1986-02-17 FI FI860711A patent/FI860711A0/fi not_active Application Discontinuation
- 1986-02-18 DK DK75986A patent/DK75986A/da not_active Application Discontinuation
- 1986-02-21 NO NO860661A patent/NO860661L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0185080B1 (de) | 1989-11-08 |
| PT80681A (de) | 1985-07-01 |
| DD240541A5 (de) | 1986-11-05 |
| NO860661L (no) | 1986-02-21 |
| IL75549A0 (en) | 1985-10-31 |
| PT80681B (de) | 1987-05-08 |
| WO1986000298A1 (fr) | 1986-01-16 |
| GR851509B (enExample) | 1985-06-25 |
| IL75549A (en) | 1989-03-31 |
| ES544439A0 (es) | 1986-02-01 |
| ES8604090A1 (es) | 1986-02-01 |
| US4711896A (en) | 1987-12-08 |
| DE3423166A1 (de) | 1986-01-02 |
| HUT38892A (en) | 1986-07-28 |
| FI860711A7 (fi) | 1986-02-17 |
| DK75986D0 (da) | 1986-02-18 |
| JPH0780807B2 (ja) | 1995-08-30 |
| JPS61502537A (ja) | 1986-11-06 |
| AU4607185A (en) | 1986-01-24 |
| ZA854684B (en) | 1986-02-26 |
| DE3574130D1 (en) | 1989-12-14 |
| CA1262552A (en) | 1989-10-31 |
| EP0185080A1 (enExample) | 1986-06-25 |
| DK75986A (da) | 1986-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI860711A0 (fi) | Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. | |
| FI863200A7 (fi) | Kolfibriller, foerfarande foer framstaellning av desamma samt kompositioner innehaollande desamma. | |
| FI851869L (fi) | Nya pyrrolo-bensimidazoler, foerfarande foer framstaellning av desamma och laekemedel innehaollande dessa foereningar samt mellanprodukter. | |
| FI842110L (fi) | Foerfarande foer styrning av saogblad, samt anordning foer utfoerande av foerfarandet. | |
| FI852203L (fi) | 7-amino-1-cyklopropyl-6, 8-dihalogen-1, 4-dihydro-4-oxo-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen. | |
| FI851533A0 (fi) | Foerfarande foer aostadkomma undertryck i en sektor av en vals, samt en sugvals. | |
| FI853611L (fi) | Bloedningshaemmande proteiner, foerfarande foer framstaellning samt deras anvaendning. | |
| FI855053L (fi) | Foerfarande foer aostadkommande av en roerelsesignal samt mri-tomografianlaeggning foer utfoerande av naemnda foerfarande. | |
| FI862893A0 (fi) | Foerfarande foer mottagning av radiosaenda meddelanden samt mottagare foer aendamaolet. | |
| FI851736L (fi) | Amidinohydrazoner av tetralin-, kromon-, tiokromon- och tetrahydrokinolinderivat, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel. | |
| FI884424A0 (fi) | Alkadienderivat, deras framstaellningsfoerfaranden, dessa innehaollande laekemedel samt mellanprodukter. | |
| FI880164A0 (fi) | Staolband samt av staolbandet framstaellt verktyg. | |
| FI861257A7 (fi) | Antistatiska hoegre n-alkyl- och n-alkenylneoalkanoamider, foerfarande foer framstaellning av dessa, antistatiska kompositioner innehaollande saodana amider samt foerfarande foer minskning av ackumulering av statiska laddningar i tvaett. | |
| FI843959A0 (fi) | Nytt foerfarande foer framstaellning av kefalosporiner, vid framstaellning av kefalosporin anvaendbar mellanprodukt samt foerfarande foer framstaellning av naemnda mellanprodukt. | |
| FI860426L (fi) | Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex. | |
| FI863837L (fi) | Foerfarande foer foerpackning av livsmedel, saerskilt matportioner samt medelst foerfarandet aostadkommen foerpackning. | |
| FI882177A0 (fi) | Diarylalkylsubstituerade alkylaminer, deras framstaellningsfoerfarande, deras anvaendning samt dessa innehaollande laekemedel. | |
| FI855085A7 (fi) | En blandning av olika dihydropyridiner, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel. | |
| FI861073L (fi) | Foerfarande foer framstaellning av guanidiner, saosom linoglirid, samt foerfarande foer framstaellning av mellanprodukter. | |
| FI842338A7 (fi) | 2-azabicyklo/2.2.2./oktanderivat, foerfarande foer framstaellning av dessa samt dessa innehaollande farmaceutiska aemnen. | |
| FI853882L (fi) | Foerfarande foer framstaellning av cellulosafiber respektive aendloesa cellulosafiber samt anordning foer utfoerande av foerfarandet. | |
| FI852914L (fi) | Fjaederkraftackumulator foer en av lasten beroende samt fjaerrstyrd frigoering av en dornfoersedd lastmottagande anordning. | |
| FI852934A0 (fi) | Foerfarande foer montering av lagerlamellen i kamrullen i en hydraulmotors kolv, lageranordning foer kamrulle samt en lagerlamell. | |
| FI840835A7 (fi) | Foerfarande foer tillverkning av en ihaolig traestaong, anordning foer tillaempning av foerfarandet samt en med foerfarandet aostadkommen ihaolig traestaong. | |
| FI893253L (fi) | Som analgetiska aemnen anvaendbara 3-karbonyl-1-aminoalkyl-1h-indoler samt framstaellning av dessa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn [patent] |
Owner name: EPIS S.A. |